文献速递眼底病与葡萄膜炎

通过脉络膜上腔途径在小型猪眼内进行视网膜下细胞递送的方法:安全性与手术结局

A Subretinal Cell Delivery Method via Suprachoroidal Access in Minipigs: Safety and Surgical Outcomes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究在24只Göttingen小型猪眼内使用新型视网膜下注射套管经脉络膜上腔途径递送人脐带组织来源细胞(palucorcel)、猪脐带组织来源细胞或溶媒,细胞与溶媒均成功递送且未泄漏入玻璃体,未见视网膜脱离或玻璃体牵引带,无显著不良事件,作者认为该技术似乎可行,可用于进一步临床开发。

要点

  • 经脉络膜上腔途径使用含微针的柔性套管可将50 μL细胞(目标浓度11.2×10⁶ cells/mL,即560,000 cells/eye)或溶媒成功递送至视网膜下。
  • 标记细胞或荧光溶媒局限于视网膜下泡内,未泄漏入玻璃体,眼科检查未发现视网膜脱离或玻璃体牵引带。
  • 异基因条件下未检测到抗体反应,异种条件下检测到抗人UTC抗体;作者认为该技术似乎可行,可用于进一步临床开发。

核心结论

  • Palucorcel、pUTC和溶媒通过新型视网膜下注射套管经脉络膜上腔手术途径成功递送至Göttingen小型猪,无显著不良事件,因此该技术似乎可行,可用于进一步临床开发。

研究设计与样本

  • 研究使用24只Göttingen小型猪,分为八组,经视网膜下给予palucorcel、pUTC或溶媒,部分动物给予荧光标记细胞和溶媒。
  • 手术操作为结膜切开和巩膜切开,插入含微针的柔性套管并推进至脉络膜上腔,展开并可视化微针后注射50 μL细胞(目标浓度11.2×10⁶ cells/mL,即560,000 cells/eye)或溶媒至视网膜下,并评估安全性结局。

主要发现

  • 所有动物的细胞和溶媒均成功给予。
  • 标记细胞或荧光溶媒局限于视网膜下泡内,未泄漏入玻璃体。
  • 眼科检查未发现视网膜脱离或玻璃体牵引带。
  • 在所有时间点,观察到的显微镜下变化均可归因于实验操作。
  • 注射后立即的组织病理学显示局部视网膜脱离,伴局灶性视网膜、脉络膜和/或巩膜连续性中断;有限数量的动物中可见中度炎症反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study evaluated a new subretinal method for delivery of human or pig umbilical tissue-derived cells (hUTC or pUTC, respectively) using a novel subretinal injection cannula and suprachoroidal approach in Göttingen minipig eyes. hUTC (palucorcel) are currently under development for treating geographic atrophy in humans. METHODS: Twenty-four Göttingen minipigs (divided into eight groups) were subretinally administered palucorcel, pUTC, or vehicle. In some cases, fluorescently labeled cells and vehicle were administered. Conjunctival cutdown and sclerotomy were performed, then a flexible cannula containing a microneedle was inserted and advanced into the suprachoroidal space. The microneedle was deployed and visualized; 50 μL cells (target concentration, 11.2 × 106 cells/mL [560,000 cells/eye]) or vehicle was injected subretinally. Safety outcomes were evaluated. RESULTS: For all animals, cells and vehicle were successfully administered. Labeled cells or fluorescent vehicle were contained in the subretinal bleb, without leakage into the vitreous. No retinal detachment or vitreous traction band was identified by ophthalmologic examination. At all time points, observed microscopic changes were attributable to experimental procedures. On histopathology immediately after injection, localized retinal detachments were seen, along with focal retinal, choroidal, and/or scleral discontinuities. A moderate inflammatory response was seen in a limited number of animals. In the allogeneic setting, no antibody responses were detectable. Anti-human UTC antibodies were detected in the xenogeneic setting. CONCLUSIONS: Palucorcel, pUTC, and vehicle were successfully administered to Göttingen minipigs using a novel subretinal injection cannula via a suprachoroidal surgical approach, with no significant adverse events; therefore, this technique appears to be feasible for further clinical development.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. de Smet MD, Lynch JL, Dejneka NS, et al. A Subretinal Cell Delivery Method via Suprachoroidal Access in Minipigs: Safety and Surgical Outcomes. Invest Ophthalmol Vis Sci. 2018. PMID: 29346488. doi:10.1167/iovs.17-22233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。